PharmaTalkRadio

What’s Next in Immuno-Oncology - A Visionary Conversation with Dr Ira Mellman

This podcast features a fireside chat between Dr Ira Mellman, PICI and Dr Axel Hoos, Former CEO, Scorpion Therapeutics from the 2026 Immuno-Oncology 360° conference. Draw

New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem

As alternative funding pathways decrease and fewer research grants are administered, the relationship between biotech and academia must shift in order to continue to achi

Developing a Global Clinical Trial Strategy for Emerging Biotechs

This podcast feature a panel discussion from the 2026 Chief Medical Officer Summit 360°, biotech CMOs and executives from CROs and consultancies. Together they discuss ho

How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions

This podcast features a panel discussion from the 2026 Chief Medical Officer Summit 360°, with biotech CMOs and representatives from pharma companies. Together, they addr

What to Expect at Partnerships with Sites 2026

Unlocking Unstructured Data with AI for Optimized Protocol Development

In this podcast, Mike Eckrote, SVP, Strategic Solutions at Advarra, talks about how artificial intelligence is being used to pull insights out of structured and unstructu

Bridging Access Gaps: Sponsor-Led Enablement of Research-Naïve Sites to Expand Patient Reach

Tapping into research-naïve sites offers a strategic opportunity to expand patient access. That’s exactly what Endo did when faced with challenges activating sites for th

Building Trust-Driven Partnerships: AstraZeneca’s Concierge Approach to Accelerating Site Activation and Enrollment

AstraZeneca’s US Site Engagement Leads will share how they are reimagining sponsor-site relationships through a trust-first, high-engagement operating model that emphasiz

Eli Lilly on Site Enablement: Co-Designing Solutions with Sites

A case study highlighting how Eli Lilly partnered with clinical sites to co-design practical, site-centric solutions that enhanced trial execution and operational efficie

What a Strategic Partnership Looks Like in Practice: Inside the Takeda–Basil Collaboration That Delivered Tenfold Enrollment

This case study highlights how Basil Clinical Research and Takeda’s first-time partnership became the top global recruiter, exceeding enrollment goals by tenfold through

Using Digital Technologies to Enhance Patient Experience and Better Manage Supply Chain

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts address:  Integrating conn

Ensuring Sustainability Throughout Drug and Device Development

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts address how the biopharma

Utilizing AI to Facilitate Combination Product Development

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives discuss specific examples of AI/ML usage by pharma c

Achieving Effective Manufacturing Scaleup for Clinical and Commercial Success

Manufacturing scaleup is a key hurdle in enabling the efficacy of new device technologies. Often this requires a mix of internal and external manufacturing and implementi

Advances and Opportunities in Dual Chamber Injectables

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess in the dev

How Evinova is Integrating AI into Clinical Development to Bring Big Impact to Big Pharma

About this Podcast:  As pharma sponsors continually assesses how to integrate AI into their ways of working, Evinova’s Chief Technology Officer, Sean Connolly, talks abou

How Bayer Reorganized Their Clinical Operations Structure for Efficiency and Cost Savings

About this podcast: Recorded at DPHARM 2025, Bayer's Dr Bernhard Glombitza reports on the development, implementation and early impact of their clinical operations reorgn

How Amicus Embedded Patient Advocacy into its Corporate DNA

About this podcast: In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their

Designing Clinical Trials Balancing Simplicity with Complexity

When designing clinical trials, CMOs aim to answer meaningful questions for a plethora of stakeholders. Inherently, this results in study protocols with more measures, bi

Platform Approaches to Streamline Combination Product Development

Investing in developing a durable platform and strategy early leads to fewer delays throughout development. Locking requirements in early and educating teams to approach